Graybug Vision Inc is a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve. The company's products under pipeline are GB-102, for the treatment of wet age-related macular degeneration, or wet AMD, and diabetic macular edema, or DME; GB-103; and GB-401.
If you want more trading ideas like this one ,ðŊ press a thumb up! ð Have a question? Don't be shy to ask! ðĪ Interested to study how to analyze charts, follow me!
If you want more trading ideas like this one ,ðŊ press a thumb up! ð Have a question? Don't be shy to ask! ðĪ Interested to study how to analyze charts, follow me!